SG10201408374WA - Therapeutic Combinations Of Theobromine And An Antihistamine - Google Patents

Therapeutic Combinations Of Theobromine And An Antihistamine

Info

Publication number
SG10201408374WA
SG10201408374WA SG10201408374WA SG10201408374WA SG10201408374WA SG 10201408374W A SG10201408374W A SG 10201408374WA SG 10201408374W A SG10201408374W A SG 10201408374WA SG 10201408374W A SG10201408374W A SG 10201408374WA SG 10201408374W A SG10201408374W A SG 10201408374WA
Authority
SG
Singapore
Prior art keywords
antihistamine
theobromine
therapeutic combinations
therapy
therapeutic
Prior art date
Application number
SG10201408374WA
Inventor
John Brew
Robin Mark Bannister
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of SG10201408374WA publication Critical patent/SG10201408374WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

8 THERAPEUTIC COMBINATIONS OF THEOBROMINE AND AN ANTIHISTAMINE Abstract An agent comprises theobromine and an antihistamine, as a combined preparation for simultaneous, sequential or separate use in therapy, particularly in the therapy of cough. Figure 1
SG10201408374WA 2009-12-14 2010-12-14 Therapeutic Combinations Of Theobromine And An Antihistamine SG10201408374WA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0921803.3A GB0921803D0 (en) 2009-12-14 2009-12-14 Drug composition and its use in therapy

Publications (1)

Publication Number Publication Date
SG10201408374WA true SG10201408374WA (en) 2015-01-29

Family

ID=41667043

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201408374WA SG10201408374WA (en) 2009-12-14 2010-12-14 Therapeutic Combinations Of Theobromine And An Antihistamine
SG2012042495A SG181603A1 (en) 2009-12-14 2010-12-14 Therapeutic combinations of theobromine and an antihistamine

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2012042495A SG181603A1 (en) 2009-12-14 2010-12-14 Therapeutic combinations of theobromine and an antihistamine

Country Status (17)

Country Link
EP (1) EP2512472A1 (en)
JP (2) JP2013513652A (en)
CN (1) CN102802625A (en)
AU (1) AU2010332495C1 (en)
BR (1) BR112012014159A8 (en)
CA (1) CA2784215A1 (en)
CO (1) CO6541638A2 (en)
GB (1) GB0921803D0 (en)
IL (1) IL220384A0 (en)
MX (1) MX2012006624A (en)
NZ (1) NZ600267A (en)
PE (1) PE20121538A1 (en)
RU (1) RU2012129675A (en)
SG (2) SG10201408374WA (en)
UA (1) UA105827C2 (en)
WO (1) WO2011073647A1 (en)
ZA (1) ZA201204294B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
CN103263533B (en) * 2013-05-31 2014-11-05 杨宏伟 Theobromine composition for treating cough and application and preparation thereof
CN104224819B (en) * 2014-09-18 2016-08-17 中山大学 A kind of naringin and levo-cetirizine hydrochloride pharmaceutical composition and preparation thereof
CN104188998A (en) * 2014-09-18 2014-12-10 中山大学 Naringin and fexofenadine hydrochloride drug composition and preparation thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3766885D1 (en) * 1986-04-17 1991-02-07 Alza Corp Chlorpheniramine therapie.
HUP9700654A2 (en) 1997-03-26 1999-09-28 Dezső Korbonits Antitussive compositions containing theobromine
JPH10316568A (en) * 1997-05-13 1998-12-02 Taisho Pharmaceut Co Ltd Pharmaceutical composition
JP2003012514A (en) * 2001-07-02 2003-01-15 Taisho Pharmaceut Co Ltd Medicament composition
JP2003128549A (en) * 2001-08-15 2003-05-08 Rohto Pharmaceut Co Ltd Composition applicable to mucous membrane
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
UY31017A1 (en) * 2007-04-11 2008-07-03 Alcon Res Ltd USE OF A FACTOR INHIBITOR & (ALPHA) OF TUMOR NECROSIS PLUS AN ANTIHISTAMINIC FOR THE TREATMENT OF ALLERGIC RHINITIS AND ALLERGIC CONJUNCTIVITIS.

Also Published As

Publication number Publication date
BR112012014159A8 (en) 2017-12-26
RU2012129675A (en) 2014-01-27
ZA201204294B (en) 2013-02-27
AU2010332495A1 (en) 2012-06-21
CO6541638A2 (en) 2012-10-16
CA2784215A1 (en) 2011-06-23
GB0921803D0 (en) 2010-01-27
IL220384A0 (en) 2012-08-30
WO2011073647A1 (en) 2011-06-23
JP2016040280A (en) 2016-03-24
NZ600267A (en) 2013-07-26
JP2013513652A (en) 2013-04-22
BR112012014159A2 (en) 2017-08-29
UA105827C2 (en) 2014-06-25
SG181603A1 (en) 2012-07-30
CN102802625A (en) 2012-11-28
MX2012006624A (en) 2012-10-05
AU2010332495B2 (en) 2015-01-22
AU2010332495C1 (en) 2016-02-11
EP2512472A1 (en) 2012-10-24
JP6078605B2 (en) 2017-02-08
PE20121538A1 (en) 2012-12-21

Similar Documents

Publication Publication Date Title
SG10201408374WA (en) Therapeutic Combinations Of Theobromine And An Antihistamine
HK1220631A1 (en) Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same
TN2013000508A1 (en) Combination therapy comprising a cdk4/6 inhibitor and a pi3k inhibitor for use in the treatment of cancer
ZA201000075B (en) Purin derivatives for use in the treatment of fab-related diseases
HK1153926A1 (en) Purin derivatives for use in the treatment of fab-related diseases fab-
SI2069342T1 (en) 2-ARYL-6-PHENYLIMIDAZO?á1,2-A?åPYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
ZA201206062B (en) Aminotetraline derivatives,pharmaceutical compositions containing them,and their use in therapy
AP2320A (en) Proline derivatives and their use as dipeptidyl peptidase IV inhibitors.
TN2012000414A1 (en) Forms of rifaximin and uses thereof
EP2395834A4 (en) Sodium nitrite-containing pharmaceutical compositions
IL180872A0 (en) Substituted 8-aminoalkylthio-xanthines, and the use thereof as inhibitors of the dipeptidyl peptidase iv
EP2461691A4 (en) Therapeutic vitamin d sun-protecting formulations and methods for their use
AU316078S (en) Surgical tissue stimulator/locator
WO2010121164A3 (en) 1,4-benzodiazepinone compounds and their use in treating cancer
MX343598B (en) Theobromine in combination with an expectorant or a mucolytic for use in therapy.
WO2011058373A3 (en) Drug combination with theobromine and its use in therapy
MX343222B (en) Combination of theobromine with a decongestant and its use for the treatment of cough.
ZA201000581B (en) 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazepine-7-carboxamide derivatives,preparation and therapeutic use thereof
UA105940C2 (en) Drug formulation with theobromine and opiate for treatment of cough
IL198481A0 (en) Pyrrole derivatives, preparation use of the same in therapy
AU302434S (en) Vibroheat capsule I
WO2010150098A3 (en) Use of quingolide in the treatment of endometriosis, pain and cancer
GB201108289D0 (en) Therapeutic garment and method of providing therapy using the same
UA43276U (en) Chuprykov-tarshynov method for treating hyperactivity in children
WO2011161465A3 (en) Composition for treatment of skin